» Articles » PMID: 35756148

Trials of Maharishi Ayurveda for Cardiovascular Disease: A Pooled Analysis of Outcome Studies with Carotid Intima-media Thickness

Overview
Date 2022 Jun 27
PMID 35756148
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate a multimodality, natural medicine systems approach-Maharishi Ayurveda (MAV)-for prevention or reversal of atherosclerotic cardiovascular disease (ASCVD).

Design: Pooled analysis of data from existing trials that used MAV to reduce carotid artery intima-media thickness (CIMT).

Settings: Two large medical centers in the U.S. Midwest.

Subjects: Thirty-four elderly patients with or at high risk for ASCVD.

Interventions: Four components of MAV: Transcendental Meditation, Ayurvedic diet, Ayurvedic exercise, and Ayurvedic herbal food supplements.

Primary Outcome Measure: CIMT, a surrogate measure of ASCVD, was determined by B-mode ultrasonography.

Results: After 9-12 months of intervention, CIMT declined in the MAV group (change in CIMT = -0.15 ± 0.22 mm; 95% CI = -0.22 to 0.01 mm) and increased in the usual care group (change in CIMT = + 0.02 ± 0.06 mm; 95% CI = -0.02 to 0.04). This difference between groups of -0.17 mm was significant [(1,29) = 14.1, << .01]. In the MAV group, those individuals showing the largest reductions in CIMT with treatment also had the highest risk factor levels at the start. Baseline data from this subgroup indicated the presence of hypertension, (systolic blood pressure (SBP) = 141 ± 11 mmHg, diastolic blood pressure (DBP) = 80 ± 12 mmHg, means ± SD). They also had elevated waist circumference (91 ± 8 cm), and dyslipidemia (triglyceride-to-HDL-cholesterol ratio = 4.8 ± 2.9). Each individual in this "high-CIMT-change" group, 80% of whom were women, improved notably in one or more risk factors with the MAV intervention.

Conclusions: The pooled results of these two trials suggest that MAV multimodality intervention programs, including the Transcendental Meditation technique and heart-healthy Ayurvedic diet, exercise, and herbal food supplements, may be effective in the regression of ASCVD, especially in patients at high risk for cardiovascular disease.

References
1.
Orme-Johnson D, Herron R . An innovative approach to reducing medical care utilization and expenditures. Am J Manag Care. 1996; 3(1):135-44. View

2.
Paul-Labrador M, Polk D, Dwyer J, Velasquez I, Nidich S, Rainforth M . Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease. Arch Intern Med. 2006; 166(11):1218-24. DOI: 10.1001/archinte.166.11.1218. View

3.
Bots M, de Jong P, Hofman A, Grobbee D . Left, right, near or far wall common carotid intima-media thickness measurements: associations with cardiovascular disease and lower extremity arterial atherosclerosis. J Clin Epidemiol. 1997; 50(7):801-7. DOI: 10.1016/s0895-4356(97)00059-0. View

4.
Nader T, Rothenberg S, Averbach R, Charles B, Fields J, SCHNEIDER R . Improvements in chronic diseases with a comprehensive natural medicine approach: a review and case series. Behav Med. 2000; 26(1):34-46. PMC: 2408890. DOI: 10.1080/08964280009595751. View

5.
Lorenz M, Markus H, Bots M, Rosvall M, Sitzer M . Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007; 115(4):459-67. DOI: 10.1161/CIRCULATIONAHA.106.628875. View